Does MYCOPHENOLATE MOFETIL Cause Second primary malignancy? 18 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 18 reports of Second primary malignancy have been filed in association with MYCOPHENOLATE MOFETIL (Mycophenolate mofetil). This represents 0.0% of all adverse event reports for MYCOPHENOLATE MOFETIL.
18
Reports of Second primary malignancy with MYCOPHENOLATE MOFETIL
0.0%
of all MYCOPHENOLATE MOFETIL reports
12
Deaths
5
Hospitalizations
How Dangerous Is Second primary malignancy From MYCOPHENOLATE MOFETIL?
Of the 18 reports, 12 (66.7%) resulted in death, 5 (27.8%) required hospitalization, and 3 (16.7%) were considered life-threatening.
Is Second primary malignancy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MYCOPHENOLATE MOFETIL. However, 18 reports have been filed with the FAERS database.
What Other Side Effects Does MYCOPHENOLATE MOFETIL Cause?
Off label use (13,474)
Drug ineffective (7,729)
Product use in unapproved indication (5,910)
Diarrhoea (3,628)
Cytomegalovirus infection (3,278)
Pneumonia (3,017)
Pyrexia (2,927)
Condition aggravated (2,883)
Covid-19 (2,706)
Transplant rejection (2,500)
What Other Drugs Cause Second primary malignancy?
CYCLOPHOSPHAMIDE (1,247)
DOXORUBICIN (1,151)
VINCRISTINE (908)
IMATINIB (763)
PALBOCICLIB (658)
RITUXIMAB (646)
RUXOLITINIB (611)
ETOPOSIDE (573)
PREDNISONE (517)
OCTREOTIDE (496)
Which MYCOPHENOLATE MOFETIL Alternatives Have Lower Second primary malignancy Risk?
MYCOPHENOLATE MOFETIL vs MYCOPHENOLATE MOFETIL\MYCOPHENOLATE MOFETIL
MYCOPHENOLATE MOFETIL vs MYCOPHENOLIC ACID
MYCOPHENOLATE MOFETIL vs MYFORTIC
MYCOPHENOLATE MOFETIL vs MYRBETRIQ
MYCOPHENOLATE MOFETIL vs NABILONE